Higher methylation level of PLK1/3 promoter was associated with poor survival probability of patients with lung adenocarcinoma (Figure 7A,C), while higher methylation level of PLK2/4 was significantly related to favourable survival probability of patients with lung adenocarcinoma (Figure 7B,D). This evidence concerns the gene PLK2 and lung adenocarcinoma.